Educational guide
HIF-1 α peptide (556-574), CAS 1201633-99-9 Peptide
HIF-1 α peptide (556-574), CAS 1201633-99-9 US$388.61 Excluding tax and shipping fees In stock Description About HIF-1 α peptide (556-574), CAS 1201633-99-9 HIF-1 α peptide (556-574), CAS 1201633-99-9 (Uniprot: Q16665) is a fragment of tumour-growth-promoting
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
HIF-1 α peptide (556-574), CAS 1201633-99-9
US$388.61
Excluding tax and shipping fees
In stock
Description
About HIF-1 α peptide (556-574), CAS 1201633-99-9
HIF-1 α peptide (556-574), CAS 1201633-99-9 (Uniprot: Q16665) is a fragment of tumour-growth-promoting transcription factor HIF-1 for cancer-targeting research. The HIF-1 α peptide (556-574), CAS 1201633-99-9 peptide, H-DLDLEMLAPYIPMDDDFQL-OH from JPT is produced under strict quality control and quality management.
HIF-1 α peptide (556-574), CAS 1201633-99-9 - Specifications
Peptide sequence: H-DLDLEMLAPYIPMDDDFQL-OH
Amount: 5 mg
Purity: > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Non-RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s Non-RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for HIF-1 α peptide (556-574), CAS 1201633-99-9
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for HIF-1 α peptide (556-574), CAS 1201633-99-9
HIF-1 peptide-556-574-CAS 1201633-99-9.pdf
Properties
Properties of HIF-1 α peptide (556-574), CAS 1201633-99-9
5 mg
Cancer biomarker research
Cancer peptides
Freeze-dried in plastic vial
Human
HIF-1 α
>90% (HPLC-MS)
No
Further Information to HIF-1 α peptide (556-574), CAS 1201633-99-9
Values
H-DLDLEMLAPYIPMDDDFQL-OH
19mer cancer peptide